creatine has been researched along with Multiple Myeloma in 15 studies
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
Excerpt | Relevance | Reference |
---|---|---|
"Recently, the safety and effectiveness of bortezomib for patients with multiple myeloma and renal failure has been reported." | 7.77 | [Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure]. ( Fujisaki, T; Kan, S; Murakami, H; Muta, T; Nakanishi, H; Senba, S; Ueda, Y; Yasunaga, M, 2011) |
"Population pharmacokinetic modelling (using NONMEM) was performed with total and unbound concentration-time data from 100 patients (36-73 years) who had received a median 192 mg m(-2) melphalan dose." | 5.36 | Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy. ( Duffull, SB; Earl, J; Gurney, H; Hegarty, G; Joshua, D; Kerridge, I; Kwan, YL; McLachlan, AJ; Nath, CE; Presgrave, P; Shaw, PJ; Tiley, C; Trotman, J; Zeng, L, 2010) |
"Recently, the safety and effectiveness of bortezomib for patients with multiple myeloma and renal failure has been reported." | 3.77 | [Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure]. ( Fujisaki, T; Kan, S; Murakami, H; Muta, T; Nakanishi, H; Senba, S; Ueda, Y; Yasunaga, M, 2011) |
"Population pharmacokinetic modelling (using NONMEM) was performed with total and unbound concentration-time data from 100 patients (36-73 years) who had received a median 192 mg m(-2) melphalan dose." | 1.36 | Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy. ( Duffull, SB; Earl, J; Gurney, H; Hegarty, G; Joshua, D; Kerridge, I; Kwan, YL; McLachlan, AJ; Nath, CE; Presgrave, P; Shaw, PJ; Tiley, C; Trotman, J; Zeng, L, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (53.33) | 18.7374 |
1990's | 2 (13.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nooka, AK | 1 |
Harvey, RD | 1 |
Langston, A | 1 |
Collins, H | 1 |
Lonial, S | 1 |
Kaufman, JL | 1 |
Kim, M | 1 |
Ju, YS | 1 |
Lee, EJ | 1 |
Kang, HJ | 1 |
Kim, HS | 1 |
Cho, HC | 1 |
Kim, HJ | 1 |
Kim, JA | 1 |
Lee, DS | 1 |
Lee, YK | 1 |
Nath, CE | 1 |
Shaw, PJ | 1 |
Trotman, J | 1 |
Zeng, L | 1 |
Duffull, SB | 1 |
Hegarty, G | 1 |
McLachlan, AJ | 1 |
Gurney, H | 1 |
Kerridge, I | 1 |
Kwan, YL | 1 |
Presgrave, P | 1 |
Tiley, C | 1 |
Joshua, D | 1 |
Earl, J | 1 |
Muta, T | 1 |
Nakanishi, H | 1 |
Yasunaga, M | 1 |
Senba, S | 1 |
Murakami, H | 1 |
Kan, S | 1 |
Ueda, Y | 1 |
Fujisaki, T | 1 |
Cho, YU | 1 |
Chi, HS | 1 |
Park, CJ | 1 |
Jang, S | 1 |
Seo, EJ | 1 |
Suh, C | 1 |
HAHNEMANN, S | 1 |
FRIIS, T | 1 |
WATKIN, DM | 1 |
STEINFELD, JL | 1 |
SOLOMON, A | 1 |
FAHEY, JL | 1 |
Davis, FB | 1 |
Medway, W | 1 |
Weber, WT | 1 |
O'Brien, JA | 1 |
Krawitz, L | 1 |
Rico, H | 1 |
Hernandez, ER | 1 |
Diaz-Mediavilla, J | 1 |
Alvarez, A | 1 |
Martinez, R | 1 |
Espinos, D | 1 |
Durie, BG | 1 |
Stock-Novack, D | 1 |
Salmon, SE | 1 |
Finley, P | 1 |
Beckord, J | 1 |
Crowley, J | 1 |
Coltman, CA | 1 |
Williams, RC | 1 |
Brunning, RD | 1 |
Wollheim, FA | 1 |
Drivsholm, A | 1 |
Videbaek, A | 1 |
Guzzo, CE | 1 |
Pachas, WN | 1 |
Pinals, RS | 1 |
Krant, MJ | 1 |
1 review available for creatine and Multiple Myeloma
Article | Year |
---|---|
Myelomatous pleural effusion: a case series in a single institution and literature review.
Topics: Adenosine Deaminase; Adult; Aged; beta 2-Microglobulin; Chromosomes, Human, Pair 13; Creatine; Diagn | 2011 |
1 trial available for creatine and Multiple Myeloma
Article | Year |
---|---|
Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study.
Topics: Age Factors; beta 2-Microglobulin; Calcium; Creatine; Humans; Multiple Myeloma; Multivariate Analysi | 1990 |
13 other studies available for creatine and Multiple Myeloma
Article | Year |
---|---|
Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.
Topics: Antineoplastic Agents, Alkylating; Creatine; Dose-Response Relationship, Drug; Female; Glomerular Fi | 2014 |
Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Chromosome Aberrations; Chromosomes, Human, Pai | 2016 |
Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy.
Topics: Adult; Aged; Area Under Curve; Creatine; Dose-Response Relationship, Drug; Female; Humans; Infusions | 2010 |
[Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure].
Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Creatine; Female; Humans; Male; Middle Aged; | 2011 |
[REABSORPTION OF PHOSPHORUS IN THE RENAL TUBULES IN NONPARATHYROGENOUS DISEASES].
Topics: Adenoma; Bone Neoplasms; Breast Neoplasms; Creatine; Creatinine; Denmark; Diagnosis, Differential; H | 1964 |
METABOLIC RELATIONSHIPS BETWEEN TUMOR AND HOST DURING MASSIVE DOSES OF PREDNISONE IN HUMAN NEOPLASTIC DISEASE.
Topics: 17-Ketosteroids; Adenocarcinoma; Biomedical Research; Blood; Calcium; Chlorides; Creatine; Creatinin | 1964 |
BENCE JONES PROTEINEMIA.
Topics: Bence Jones Protein; Blood Protein Electrophoresis; Blood Sedimentation; Calcium; Calcium, Dietary; | 1964 |
The treatment of hypercalcemia with inorganic phosphate salts.
Topics: Adult; Aged; Blood Urea Nitrogen; Breast Neoplasms; Calcium; Carcinoma, Squamous Cell; Creatine; Fem | 1967 |
Multiple myeloma in a dog.
Topics: Alkaline Phosphatase; Animals; Blood Proteins; Blood Sedimentation; Blood Urea Nitrogen; Bone Marrow | 1967 |
Treatment of multiple myeloma with nasal spray calcitonin: a histomorphometric and biochemical study.
Topics: Administration, Intranasal; Adult; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Calci | 1990 |
Light-chain disease. An abortive variant of multiple myeloma.
Topics: Agammaglobulinemia; Bence Jones Protein; Blood Protein Electrophoresis; Bone Marrow; Bone Marrow Cel | 1966 |
Alkeran (Melphalan) in the treatment of myelomatosis.
Topics: Adult; Aged; Blood Platelets; Blood Proteins; Creatine; Female; Humans; Hypercalcemia; In Vitro Tech | 1966 |
Urinary hydroxyproline excretion in patients with cancer.
Topics: Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Calcium; Collagen; Creatine; Female; Humans; | 1969 |